Plasma serotonin levels are elevated in pregnant women with hyperemesis gravidarum

Archives of Gynecology and Obstetrics

Volumn 291, Issue 6, 2015, Pages 1271-1276

  Cengiz, Huseyin ^a   Dagdeviren, Hediye ^a   Caypinar, Sema Suzen ^a   Kanawati, Ammar ^a   Yildiz, Sukru ^a   Ekin, Murat ^a  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hyperemesis gravidarum; Ondansetron; Pathogenesis; Serotonin; Thyroid hormones

Indexed keywords

SEROTONIN;

ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPEREMESIS GRAVIDARUM; PREGNANCY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TURKEY;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY; SEROTONIN; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 84939940274     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3572-2     Document Type: Article

References (23)

1. Quinla JD, Ashley Hill D (2003) Nausea and vomiting of pregnancy. Am Fam Physician 68:121–128
2. Lee NM, Saha S (2011) Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 40:309
3. Aka N, Atalay S, Sayharman S, Kiliç D, Köse G, Küçüközkan T (2006) Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol 46:274–277
4. Doggrell SA (2003) The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation. Expert Opin Investig Drugs 12:805–823
5. McNulty R (2007) Are all 5-HT3 receptor antagonists the same? J Natl Compr Canc Netw 5:35
6. Guikontes E, Spantideas A, Diakadis J (1992) Ondansetron and hyperemesis gravidarum. Lancet 340:1223
7. World MJ (1993) Ondansetron and hyperemesis gravidarum. Lancet 341:185
8. Borgeat A, Fathi M, Valiton A (1997) Hyperemesis gravidarum: is serotonin implicated. Am J Obstet Gynecol 176:476–477
9. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A (2008) Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol 198:71.e1–71.e7. doi:10.1016/j.ajog.2007.05.051
10. Abell TL, Riel CA (1992) Hyperemesis gravidarum. Gastroenterol Clin North Am 21:835–849
11. Lagiou P, Tamimi R, Mucci LA, Trichopoulos D, Adami HO, Hsieh CC (2003) Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol 101:639
12. Kimura M, Amino N, Tamaki H, Ito E, Mitsuda N, Miyai K, Tanizawa O (1993) Gestational thyrotoxicosis and hyperemesis gravidarum: possible role of hCG with higher stimulating activity. Clin Endocrinol (Oxf). 38:345
13. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM (1992) The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 75:1333
14. Huxley R (2000) Nausea and vomiting in early pregnancy; its role in placental development. Obstet Gynecol 95:779–782
15. Arslan EO, Cengiz L, Arslan M (2003) Thyroid function in hyperemesis gravidarum and correlation with serum leptin levels. Int J Gynecol Obstet 83:187–188
16. Yoshimura M, Hershman JM (1995) Thyrotropic action of human chorionic gonadotrophin. Thyroid 5:425–434
17. Oruç AS, Mert I, Akturk M, Aslan E, Polat B, Buyukkagnıcı U, Danışman N (2013) Ghrelin and motilin levels in hyperemesis gravidarum. Arch Gynecol Obstet 287:1087–1092. doi:10.1007/s00404-012-2705-8
18. Goodwin TM (2008) Hyperemesis gravidarum. Obstet Gynecol Clin N Am 35:401–417
19. Hasler WL (1999) Serotonin receptor physiology: relation to emesis. Dig Dis Sci 44:108S–118S
20. Gershon MD (2004) Review article: serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20(Suppl 7):3–14
21. Hickok JT, Roscoe JA, Morrow GR, Bole CW, Zhao H, Hoelzer KL, Dakhil SR, Moore T, Fitch TR (2005) 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol 6:765–772
22. Pasternak B, Svanström H, Hviid A (2013) Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med 368:814–823
23. Rubenstein EB, Slusher BS, Rojas C, Navari RM (2006) New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations. Cancer J 12:341–347